Edition:
United States

Medivation Inc (MDVN.O)

MDVN.O on Nasdaq

62.63USD
22 Jul 2016
Change (% chg)

-- (--)
Prev Close
$62.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,256,280
52-wk High
$63.35
52-wk Low
$26.41

Latest Key Developments (Source: Significant Developments)

Sanofi raises Medivation offer, enters confidentiality agreement
Tuesday, 5 Jul 2016 04:28pm EDT 

Sanofi statement: Sanofi confirms it has entered into a confidentiality agreement with Medivation under which it will be provided due diligence access and confidential information. . Says that it advised Medivation that upon signing a confidentiality agreement and being provided information, it would increase its offer to $58.00 in cash $3.00 in form of a contingent value right (cvr) relating to talazoparib sales performance. . Says a dataroom will be opened and management meetings scheduled in near term. . Under the confidentiality agreement, Sanofi has agreed to a customary standstill for six months subject to limited early termination events and has agreed to withdraw its consent solicitation. .Sanofi is confident that its due diligence can be quickly completed and that if an agreement is reached on a mutually acceptable transaction, Sanofi can close promptly given that it has received U.S. regulatory clearance, and there would be no financing condition..  Full Article

Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC
Tuesday, 28 Jun 2016 09:56am EDT 

CNBC (Bengaluru Newsroom:.  Full Article

Medivation and Astellas initiate Phase III trial of enzalutamide
Thursday, 2 Jun 2016 07:00am EDT 

Medivation Inc : Astellas and Medivation initiate Phase III trial of enzalutamide in patients with triple-negative breast cancer .Trial, which will be led by Medivation, is expected to begin patient enrollment in Q4 of 2016.  Full Article

Medivation sets record date for Sanofi's proposed consent solicitation
Wednesday, 1 Jun 2016 06:45pm EDT 

Medivation Inc : Medivation sets record date for Sanofi's proposed consent solicitation . Says accordance with Sanofi's request, company's board of directors has set close of business on June 1, 2016 .In accordance with request, co's board of directors has set close of business on June 1, as record date for Sanofi consent solicitation.  Full Article

Sanofi requests record date for consent solicitation to remove and replace Medivation's board
Wednesday, 1 Jun 2016 02:15pm EDT 

Sanofi SA : Latest day Medivation board can set record date is June 22, 2016 . Sanofi requests record date for consent solicitation to remove and replace Medivation's board of directors .Pursuant to terms of its bylaws, Medivation is required to adopt a resolution fixing record date within 10 calendar days of request.  Full Article

Sanofi expected to request record date from Medivation today - CNBC, citing sources
Wednesday, 1 Jun 2016 09:52am EDT 

: Sanofi expected to request record date from Medivation today- CNBC, citing sources (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780).  Full Article

Medivation says urges stockholders to reject Sanofi's attempt to replace co's board of directors
Wednesday, 25 May 2016 09:00am EDT 

Medivation Inc : Medivation urges stockholders to reject sanofi's attempt to replace medivation board of directors . Expects to promptly file consent revocation materials with u.s. Securities and exchange commission .Believes sanofi's attempt to replace board is a "tactic for sanofi to facilitate" its proposal to acquire medivation.  Full Article

Sanofi sends letter to Medivation board of directors
Wednesday, 25 May 2016 08:43am EDT 

Sanofi : Sanofi files consent solicitation to remove and replace Medivation's board . Today sent letter to the Medivation board of directors . Sanofi to Medication board - "Request that you engage in good faith with Sanofi as part of a sale process" . Sanofi to Medication board - "If you" engage in good faith, "we would not need to proceed" with consent solicitation to replace Medivation directors Further company coverage: [SASY.PA] ((Bengaluru Newsroom; +1 646 223 8780;)).  Full Article

Sanofi seeking to replace entire Medivation board - CNBC
Friday, 13 May 2016 09:20am EDT 

: Sanofi seeking to replace entire Medivation board; Will nominate 8 people to replace Medivation board - CNBC . Sanofi likely to have slate of new Medivation board members ready by end of next week- CNBC Further company coverage: [MDVN.O] (Bengaluru Newsroom: +1-646-223-8780).  Full Article

Sanofi files for Hart-Scott-Rodino notification regarding proposed acquisition of Medivation
Thursday, 12 May 2016 02:17pm EDT 

Sanofi SA : Scott-Rodino notification regarding proposed acquisition of Medivation .Sanofi says "reiterates commitment to consummating transaction".  Full Article

Photo

Medivation agrees to open its books to Sanofi

U.S. cancer drug company Medivation Inc said on Tuesday it had agreed to provide confidential information to French pharmaceutical company Sanofi SA as part of exploring a sale that would be open to other bidders. | Video